Drug Trial Radar · NCT00492258
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
Last checked: Nov 20, 2026Latest source record: Aug 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,656
Planned (sponsor's estimate)
Start
Jun 2007
Primary completion
Aug 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Medical Research CouncilGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jun 27, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sorafenib after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sorafenib is more effective than a placebo in treating kidney cancer. PURPOSE: This randomized phase III trial is studying sorafenib to see how well it works compared with a placebo in treating patients at risk of relapse after undergoing surgery to remove kidney cancer.
Conditions
- Kidney Cancer
Interventions
sorafenib tosylateDrug
adjuvant therapyProcedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free survival
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Royal Bournemouth Hospital
Bournemouth, England, United Kingdom
Bristol Haematology and Oncology Centre
Bristol, England, United Kingdom
Queen's Hospital
Burton-on-Trent, England, United Kingdom
Addenbrooke's Hospital
Cambridge, England, United Kingdom
Gloucestershire Oncology Centre at Cheltenham General Hospital
Cheltenham, England, United Kingdom
Derbyshire Royal Infirmary
Derby, England, United Kingdom
Dorset County Hospital
Dorchester, England, United Kingdom
Gloucestershire Royal Hospital
Gloucester, England, United Kingdom
Diana Princess of Wales Hospital
Grimsby, England, United Kingdom
Princess Royal Hospital at Hull and East Yorkshire NHS Trust
Hull, England, United Kingdom
Ipswich Hospital
Ipswich, England, United Kingdom
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, United Kingdom
Leicester Royal Infirmary
Leicester, England, United Kingdom
Lincoln County Hospital
Lincoln, England, United Kingdom
Saint Bartholomew's Hospital
London, England, United Kingdom
Medical Research Council Clinical Trials Unit
London, England, United Kingdom
Guy's Hospital
London, England, United Kingdom
Royal Marsden - London
London, England, United Kingdom
Charing Cross Hospital
London, England, United Kingdom
Maidstone Hospital
Maidstone, England, United Kingdom
Christie Hospital
Manchester, England, United Kingdom
Clatterbridge Centre for Oncology
Merseyside, England, United Kingdom
James Cook University Hospital
Middlesbrough, England, United Kingdom
Northern Centre for Cancer Treatment at Newcastle General Hospital
Newcastle upon Tyne, England, United Kingdom
Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Derriford Hospital
Plymouth, England, United Kingdom
Dorset Cancer Centre
Poole Dorset, England, United Kingdom
Portsmouth Oncology Centre at Saint Mary's Hospital
Portsmouth Hants, England, United Kingdom
Whiston Hospital
Prescot Merseyside, England, United Kingdom
Berkshire Cancer Centre at Royal Berkshire Hospital
Reading, England, United Kingdom
Scarborough General Hospital
Scarborough, England, United Kingdom
Scunthorpe General Hospital
Scunthorpe, England, United Kingdom
Cancer Research Centre at Weston Park Hospital
Sheffield, England, United Kingdom
Wexham Park Hospital
Slough, Berkshire, England, United Kingdom
Southampton General Hospital
Southampton, England, United Kingdom
University Hospital of North Staffordshire
Stoke-on-Trent, England, United Kingdom
Torbay Hospital
Torquay, England, United Kingdom
Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom
Velindre Cancer Center at Velindre Hospital
Cardiff, Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.